ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

HLA Broad Antigen and Eplet Mismatches in Determining the Risk of Acute Rejection After Kidney Transplantation

H. Do Nguyen,1 W. Lim,1,2 J. Chapman,3 J. Craig,3,4 G. Wong.3,4

1School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia
2Renal Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
3Nephrology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
4School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Meeting: 2015 American Transplant Congress

Abstract number: 28

Keywords: Epitopes, Histocompatibility antigens, Kidney transplantation, Rejection

Session Information

Date: Sunday, May 3, 2015

Session Name: Concurrent Session: Kidney Antibody Mediated Rejection I

Session Time: 2:15pm-3:45pm

 Presentation Time: 2:27pm-2:39pm

Location: Terrace I-III

Related Abstracts
  • Comparative Survival Benefits and Costs of an Eplet and Broad Antigen Based Matching System in Deceased Donor Kidney Transplant Allocation Among Indigenous Australians
  • HLA-Cw Mismatches Are Not Associated With Worse Graft Outcomes After Kidney Transplantation Even in High Levels of Antigen Expression

Aim: To determine the clinical relevance of HLA-ABDR broad antigen and eplet matching for predicting acute rejection after kidney transplantation.

Background: HLAMatchmaker determines structurally HLA compatibility at the epitope level and may better predict the immunological risk of kidney transplants compared with broad antigen matching.

Methods: Donor-recipient broad antigen and eplet HLA-ABDR mismatches were calculated for all primary kidney transplants (n=3449) in Australia (2006-2011). Test performance characteristics of broad antigen and eplet matching for predicting acute rejection were examined using Receiver Operating Characteristic (ROC) analysis and net reclassification improvement (NRI).

Results: Of 3449 transplants with mean follow-up 3.6 (SD=1.8) years, 647 (19%) had acute rejection. There was a linear increase in the rejection risk with more broad antigen mismatches (p⟨0.001) whereby grafts with 5-6 mismatches was 90% more likely to experience acute rejection than grafts with 0-2 mismatches (OR 1.92, 95% CI 1.50-2.45). A similar association was present with eplet mismatches whereby grafts with ⟩20 HLA-ABDR eplet mismatches was 90% more likely to experience acute rejection than grafts with ⟨10 HLA-ABDR eplet mismatches (OR 1.89, 95% CI 1.4-2.56). Using broad antigen matching alone, the AUC of the ROC curve was 0.583 compared with 0.635 using a combination (Figure1). The NRI of rejection risk using eplet and broad antigen matching compared with broad antigen matching alone was -0.8% (p=0.408).

Conclusions: There was a linear association between risk of acute rejection and both eplet and broad antigen mismatch. The predictive accuracy of the model did not improve significantly with the addition of eplet matching compared to broad antigen HLA matching alone for predicting acute rejection in our cohort of kidney transplant recipients.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Nguyen HDo, Lim W, Chapman J, Craig J, Wong G. HLA Broad Antigen and Eplet Mismatches in Determining the Risk of Acute Rejection After Kidney Transplantation [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/hla-broad-antigen-and-eplet-mismatches-in-determining-the-risk-of-acute-rejection-after-kidney-transplantation/. Accessed January 19, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.